<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Direct-to-Consumer Drug Ads Minimize Risks, Exaggerate Benefits</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2004/04/30/Direct-to-Consumer-Drug-Ads-Minimize-Risks-Exaggerate-Benefits.aspx</link><description>As I wrote over two years ago , since the mid-1990s pharmaceutical companies have tripled the amount of money they spend on advertising prescription drugs directly to consumers. These direct-to-consumer (DTC) ads often minimize the risks and exaggerate</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>